欧洲临床药理学与治疗学协会（EACPT）第二届大会官方卫星研讨会：P-糖蛋白及相关转运体的临床药理学。第二部分。德国柏林，1997年9月16日。 - Suppr | 超能文献

Official satellite symposium of the 2nd Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT): Clinical pharmacology of P-glycoprotein and related transporters. Part II. Berlin, Germany, September 16, 1997.

出版信息

Int J Clin Pharmacol Ther. 1998 Feb;36(2):61-113.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Official satellite symposium of the 2nd Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT): Clinical pharmacology of P-glycoprotein and related transporters. Part II. Berlin, Germany, September 16, 1997.

Int J Clin Pharmacol Ther. 1998 Feb;36(2):61-113.

2

Proceedings of the official satellite symposium of the 2nd Congress of the European Association of Clinical Pharmacology and Therapeutics (EACPT): Clinical pharmacology of P-glycoprotein and related transporters. Part I. Berlin, Germany, September 16, 1997.

Int J Clin Pharmacol Ther. 1998 Jan;36(1):1-60.

3

2nd Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Berlin, Germany, 17-20 September 1997. Abstracts.

Eur J Clin Pharmacol. 1997;52 Suppl:A29-198.

4

Microsomes, drug oxidation, and clinical pharmacology. Proceedings of a satellite symposium of the 2nd Congress of the European Association for Clinical Pharmacology and Therapeutics. Berlin, Germany, September 20-21, 1997. Dedicated to Alfred George Hildebrandt on the occasion of his 60th birthday.

Drug Metab Rev. 1999 May;31(2):297-560.

5

Drug utilization in Europe--report of the EURO-DURG workshop and joint symposium with the EACPT Berlin 16.9-18.9 1997. European Drug Utilization Research Group. European Association for Clinical Pharmacology and Therapeutics.

Int J Clin Pharmacol Ther. 1998 Mar;36(3):176-9.

6

Microsomes, drug oxidation, and clinical pharmacology. Satellite symposium following the 2nd Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT).

Skin Pharmacol Appl Skin Physiol. 1998 Jan-Feb;11(1):57-60. doi: 10.1159/000029809.

7

Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.

Cancer Res. 2007 Nov 15;67(22):11012-20. doi: 10.1158/0008-5472.CAN-07-2686.

8

Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2.

Leukemia. 2008 Feb;22(2):445-7. doi: 10.1038/sj.leu.2404897. Epub 2007 Aug 9.

9

Transport proteins in drug resistance: biology and approaches to circumvention.

J Intern Med Suppl. 1997;740:133-7.

10

Pharmacogenetics of ATP-binding cassette transporters and clinical implications.

Methods Mol Biol. 2010;596:95-121. doi: 10.1007/978-1-60761-416-6_6.